Central Awareness in Women With Endometriosis
Recruiting · NCT06773065 · Observational (researchers observe without assigning treatment) · Lead sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
View the official record on ClinicalTrials.gov →What this trial is about
Gathering some information obtained during the gynaecological examination and transvaginal ultrasound check-up to be able to assess the prevalence of Central Sensitisation Syndrome (CSS) in women with endometriosis and also to be able to assess related risk factors. CSS has been defined as an algic syndrome due to a hyperactivation of the sensitivity circuit at a central level; the diagnosis is based on the result obtained from a questionnaire, the Central Sensitisation Inventory (CSI), which evaluates the presence and intensity of 25 clinical symptoms. For this reason, a questionnaire is proposed to be completed at the time of the check-up visit.
Who can take part
Inclusion criteria
- Women with a clinical, ultrasound and/or surgical diagnosis of endometriosis
- Aged between 18 and 50 years
- Patients starting or already taking hormone therapy
- Patients coming for a first visit or outpatient follow-up visit
- Signature of informed consent to participate in the study
Exclusion criteria
- Post-menopausal women (spontaneous or iatrogenic)
- Virgo patients
- Patients with poor compliance with hormone therapy, who are not taking it properly or have discontinued therapy spontaneously
- Positive history of any malignant neoplasm
- Positive medical history of specific medical conditions that adversely affect the central nervous system, such as: brain or spinal cord damage, neurological diseases or peripheral nerve damage, multiple sclerosis
Where it is running
1 location listed.
- IRCCS Azienda Ospedaliero-Universitaria di Bologna - Bologna, Italy